Evidence map›Paper›PMID 30079350›Full record

ReviewBioMed research international2018

Boosting Secondary Metabolite Production and Discovery through the Engineering of Novel Microbial Biosensors.

Ulysses Amancio de Frias, Greicy Kelly Bonifacio Pereira, María-Eugenia Guazzaroni, Rafael Silva-Rocha

Abstract readReview
In one paragraph

Review in BioMed research international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ulysses Amancio de FriasMedical School of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil.
Greicy Kelly Bonifacio PereiraMedical School of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil.
María-Eugenia GuazzaroniFaculty of Philosophy, Science and Letters of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil.ORCID 0000-0002-4657-3731
Rafael Silva-RochaMedical School of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil.ORCID 0000-0001-6319-631X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacteria are a source of a large number of secondary metabolites with several biomedical and biotechnological applications. In recent years, there has been tremendous progress in the development of novel synthetic biology approaches both to increase the production rate of secondary metabolites of interest in native producers and to mine and reconstruct novel biosynthetic gene clusters in heterologous hosts. Here, we present the recent advances toward the engineering of novel microbial biosensors to detect the synthesis of secondary metabolites in bacteria and in the development of synthetic promoters and expression systems aiming at the construction of microbial cell factories for the production of these compounds. We place special focus on the potential of Gram-negative bacteria as a source of biosynthetic gene clusters and hosts for pathway assembly, on the construction and characterization of novel promoters for native hosts, and on the use of computer-aided design of novel pathways and expression systems for secondary metabolite production. Finally, we discuss some of the potentials and limitations of the approaches that are currently being developed and we highlight new directions that could be addressed in the field.

Indexed as

BacteriaBiosensing TechniquesGram-Negative BacteriaSynthetic BiologyMetabolic EngineeringMultigene Family

Identifiers

PMID30079350
PMCPMC6069586

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.